期刊文献+

运用PDCA预防与控制住院患者多重耐药菌感染的成效 被引量:11

Effect of PDCA on preventing and controlling multidrug-resistant orga-nism infection in hospitalized patients
下载PDF
导出
摘要 目的运用质量管理工具PDCA干预多重耐药菌感染的管理成效,以及在疾病诊断相关分组/按病种分值付费(DRG/DIP)收费模式下对医疗机构的影响。方法回顾性收集某三甲医院2021年11月1日—12月31日多重耐药菌感染预防与控制措施落实情况,以及多重耐药菌感染高发科室的感染相关指标。2022年3月1日—4月30日采用PDCA进行干预,对比干预前后多重耐药菌感染预防与控制措施落实率、多重耐药菌感染发生率、平均住院日、平均住院费用。结果PDCA干预前后多重耐药菌感染预防与控制措施落实率由61.94%提高至88.35%,干预后各多重耐药菌感染高发科室多重耐药菌感染发生率、平均住院日、平均住院费用较干预前均出现不同程度下降,差异均具有统计学意义(均P<0.05)。结论科学使用PDCA能够提高多重耐药菌感染预防与控制措施落实率,降低医院感染发生率及平均住院费用,缩短平均住院日,能避免在DRG/DIP收费模式下医疗机构出现医疗费用亏损的案例。 Objective To understand the management effectiveness of the intervention in multidrug-resistant organism(MDRO)infection through quality management tool plan-do-check-act(PDCA),and evaluate the impact in healthcare institutions under the diagnosis-related group/diagnosis-intervention packet(DRG/DIP)charging model.Methods The implementation of the prevention and control measures for MDRO infection in a tertiary first-class hospital from November 1 to December 31,2021,and the infection-related indicators of the departments with high MDRO infection incidence were collected retrospectively.From March 1 to April 30,2022,PDCA was adopted for intervention.The implementation rate of the prevention and control measures for MDRO infection,the incidence of healthcare-associated infection(HAI),the average length of hospital stay,and the average expense of hospitalization before and after the intervention were compared.Results The implementation rate of prevention and control measures for MDRO infection before and after PDCA intervention increased from 61.94%to 88.35%.After PDCA intervention,the incidence of MDRO HAI,the average length of hospital stay and the average hospitalization expenses of departments with high incidence of MDRO infection decreased compared with those before the intervention,with statistically significant differences(all P<0.05).Conclusion The scientific use of PDCA can improve the implementation rate of the prevention and control measures for MDRO infection,and decrease the incidence of HAI and the average hospitalization expenses,as well as shorten the average length of hospital stay,thus avoid medical expense loss in medical institutions under the DRG/DIP charging mode.
作者 魏德杰 王风燕 李爱珍 岳采雪 王露露 WEI De-jie;WANG Feng-yan;LI Ai-zhen;YUE Cai-xue;WANG Lu-lu(Infection Control Management Office,Puyang Oilfield General Hospital,Puyang 457000,China)
出处 《中国感染控制杂志》 CAS CSCD 北大核心 2023年第4期478-483,共6页 Chinese Journal of Infection Control
关键词 疾病诊断相关分组/按病种分值付费 PDCA 多重耐药菌 干预 DRG/DIP PDCA multidrug-resistant organism intervention
  • 相关文献

参考文献13

二级参考文献140

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2文进,谢瑜,高晓凤,孙丁,李幼平,旷翠萍,谢逸琼,王羽,张宗久,赵明钢,陆君,柳琪林,Phil Wiffen(审校).美国飓风风险管理的循证评价及其对我国医疗风险管理的启示——医疗风险系列研究之三[J].中国循证医学杂志,2006,6(3):209-217. 被引量:18
  • 3Magiorakos A P,Srinivasan A,Carey R B. Multidrug-resistant,extensively drug-resistant and pandrug-resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance[J].{H}Clinical Microbiology and Infection,2012,(3):268-281.
  • 4Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug re sistant, extensively drug-resistant and pandrug-resistant bacte ria: an international expert proposal for interim standard deft nitions for acquired resistance[J]. Clin Microbiol Infect, 2012 18(3) =268- 281.
  • 5Eckmanns T, Bessert J, Behnke M, et al. Compliance with antiseptic hand rub use in intensive care units: the Hawthorne effect FJ~. Infect Control Hosp Epidemiol, 2006, 27 (9): 931 - 934.
  • 6Kohli E, Ptak J, Smith R, et al. Variability in the Hawthorne effect with regard to hand hygiene performance in high- and low per{orming inpatient care units[J]. Infect Control Hosp Epidemiol, 2009, 30(3): 222-225.
  • 7T6rok ME, Chantratita N, Peacock SJ. Bacterial gene loss as a mechanism for gain of antimicrobial resistance[J]. Curr Opin Microbiol,2012,15(5) :583 - 587.
  • 8戴丽心.常见多重耐药菌的耐药机制及防治对策[J].医药前沿,2013,(7):119-120.
  • 9Center for Disease Control and Prevention. National strategy for com- bating antibiotic resistance[R]. Washinton:The White House,2014.
  • 10Krziwanek K, Luger C, Sammer B, et al. MRSA in Austria-- an overview[J]. Clin Microbiol Infect, 2008,14 (3) : 250 - 259.

共引文献731

同被引文献125

引证文献11

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部